Fast Five Quiz: Management of Obesity

Elif A. Oral, MD; Evelyn S. Marienberg, MD

Disclosures

December 19, 2022

Individuals may be responders or nonresponders to antiobesity drugs. According to Hamdy and colleagues, "if a patient's response to a weight loss medication is deemed effective (weight loss of 5% or more of body weight at 3 mo) and safe, it is recommended that the medication be continued. If deemed ineffective (weight loss less than 5% at 3 mo) or if there are safety or tolerability issues at any time, it is recommended that the medication be discontinued and alternative medications or referral for alternative treatment approaches be considered."

If this is not attained, the antiobesity drug should be stopped and alternative medications or referral for alternative treatment approaches be considered.

Learn more about pharmacologic approaches for obesity management.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....